Interferon-α generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection
- 1 September 2001
- journal article
- basic science
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (13) , 1603-1612
- https://doi.org/10.1097/00002030-200109070-00002
Abstract
To quantify the effect of HIV infection and HIV-suppressive therapy on interferon-alpha (IFN-alpha) production by human blood mononuclear cells; to compare, in parallel, effects on CD4+ T-cell numbers; and to ascertain the relationship of these interferon and CD4 parameters to resistance to opportunistic infections. Serial studies of 294 unselected patients with HIV infection during therapy, with outcomes analysis. Determination of IFN generation by blood mononuclear cells via bioassay, and T-lymphocyte subset analysis via flow cytometry; serial studies of individual patients; linear regression and chi2 contingency table analysis. HIV burden is inversely related to interferon-alpha generation, much as it is to CD4+ T-cell counts. Both of these recover during HIV-suppressive therapy. Reconstitution of IFN-alpha generation to levels commensurate with protection against opportunistic infection occurs prior to similar restoration of CD4 counts. In the outcomes analyses, such immune reconstitution was associated with protection from recurrent or new opportunistic infection. Conversely, viral suppression without such immunologic recovery was not protective against opportunistic infection. Rapidly responding IFN-alpha generating cells appear to participate in resistance to opportunistic intracellular infection. Recovery of IFN-alpha generation may be an early marker of immune reconstitution in AIDS.Keywords
This publication has 41 references indexed in Scilit:
- Recovery of Hematopoietic Activity in Bone Marrow from Human Immunodeficiency Virus Type 1-Infected Patients during Highly Active Antiretroviral TherapyAIDS Research and Human Retroviruses, 2000
- Immune Reconstitution after 2 Years of Successful Potent Antiretroviral Therapy in Previously Untreated Human Immunodeficiency Virus Type 1–Infected AdultsThe Journal of Infectious Diseases, 1999
- Decrease of Cytomegalovirus Replication in Human Immunodeficiency Virus Infected–Patients after Treatment with Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 1999
- Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapySexually Transmitted Infections, 1999
- Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infectionImmunology Letters, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-LigandThe Journal of Experimental Medicine, 1997
- Decreased Frequency of Functional Natural Interferon-Producing Cells in Peripheral Blood of Patients with the Acquired Immune Deficiency SyndromeClinical Immunology and Immunopathology, 1994
- Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity.Journal of Clinical Investigation, 1986
- Human peripheral null lymphocytes II. Producers of type‐1 interferon upon stimulation with tumor cells, Herpes simplex virus and Corynebacterium parvumEuropean Journal of Immunology, 1980